Stock News

$0.60 EPS Expected for Cantel Medical Corp. (CMD); Shorts at Mantech International – Class A Common (MANT) Lowered By 39.6%

ManTech International Corporation (NASDAQ:MANT) Logo

Mantech International Corporation – Class A Common (NASDAQ:MANT) had a decrease of 39.6% in short interest. MANT’s SI was 319,200 shares in May as released by FINRA. Its down 39.6% from 528,500 shares previously. With 433,600 avg volume, 1 days are for Mantech International Corporation – Class A Common (NASDAQ:MANT)’s short sellers to cover MANT’s short positions. The SI to Mantech International Corporation – Class A Common’s float is 1.24%. The stock increased 1.82% or $0.96 during the last trading session, reaching $53.79. About 190,084 shares traded. ManTech International Corporation (NASDAQ:MANT) has risen 57.61% since May 21, 2017 and is uptrending. It has outperformed by 46.06% the S&P500.

Analysts expect Cantel Medical Corp. (NYSE:CMD) to report $0.60 EPS on May, 31 before the open.They anticipate $0.09 EPS change or 17.65% from last quarter’s $0.51 EPS. CMD’s profit would be $25.03 million giving it 53.38 P/E if the $0.60 EPS is correct. After having $0.59 EPS previously, Cantel Medical Corp.’s analysts see 1.69% EPS growth. The stock increased 0.49% or $0.63 during the last trading session, reaching $128.11. About 167,366 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 41.41% since May 21, 2017 and is uptrending. It has outperformed by 29.86% the S&P500.

Among 2 analysts covering Cantel Medical (NYSE:CMD), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Cantel Medical had 2 analyst reports since March 17, 2017 according to SRatingsIntel. The stock has “Mkt Perform” rating by Raymond James on Friday, March 17. Benchmark downgraded the shares of CMD in report on Friday, June 9 to “Hold” rating.

More news for Cantel Medical Corp. (NYSE:CMD) were recently published by: Bizjournals.com, which released: “Cantel Medical leases Sleep Number’s former headquarters” on May 17, 2018. Benzinga.com‘s article titled: “Jim Cramer Weighs In On Align Technology, Berkshire Hathaway, Symantec And More” and published on May 15, 2018 is yet another important article.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $5.34 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 59.42 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Among 9 analysts covering Mantech International Corporation (NASDAQ:MANT), 4 have Buy rating, 2 Sell and 3 Hold. Therefore 44% are positive. Mantech International Corporation had 30 analyst reports since July 28, 2015 according to SRatingsIntel. As per Thursday, November 2, the company rating was maintained by Loop Capital. The stock of ManTech International Corporation (NASDAQ:MANT) earned “Underperform” rating by Wells Fargo on Tuesday, August 30. The firm has “Hold” rating given on Tuesday, July 28 by BB&T Capital. Maxim Group maintained ManTech International Corporation (NASDAQ:MANT) on Wednesday, September 20 with “Buy” rating. The stock of ManTech International Corporation (NASDAQ:MANT) has “Hold” rating given on Wednesday, November 30 by Maxim Group. As per Wednesday, October 25, the company rating was maintained by Wells Fargo. The stock of ManTech International Corporation (NASDAQ:MANT) has “Buy” rating given on Thursday, February 18 by Maxim Group. The stock has “Buy” rating by Cowen & Co on Friday, April 6. The rating was maintained by Cowen & Co on Thursday, February 22 with “Outperform”. The stock of ManTech International Corporation (NASDAQ:MANT) has “Buy” rating given on Thursday, October 12 by Cowen & Co.

ManTech International Corporation provides technologies and solutions for mission-critical national security programs worldwide. The company has market cap of $2.13 billion. It offers cyber security solutions and services. It has a 18.45 P/E ratio. The firm also designs, develops, integrates, operates, and sustains software applications and systems across defense, intelligence, and federal civilian customers; and provides hardware and software to support the technology infrastructure for specific applications, including IT service management, help desk, data center consolidation, enterprise architecture, mobile computing and device management, network activities and infrastructure, virtualization/cloud computing, network and database administration, enterprise systems development and management, and infrastructure as a service.

More important recent ManTech International Corporation (NASDAQ:MANT) news were published by: Globenewswire.com which released: “ManTech Announces Financial Results for First Quarter of 2018” on May 02, 2018, also Seekingalpha.com published article titled: “ManTech International (MANT) Q1 2018 Results – Earnings Call Transcript”, Benzinga.com published: “Benzinga’s Top Upgrades, Downgrades For May 17, 2018” on May 17, 2018. More interesting news about ManTech International Corporation (NASDAQ:MANT) was released by: Investorplace.com and their article: “5 Defense Stocks to Tap US-North Korea Denuclearization Row” with publication date: May 17, 2018.

ManTech International Corporation (NASDAQ:MANT) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *